EDGAR Filing Documents for 0001193125-20-063716

Form 8-K - Current report:

SEC Accession No. 0001193125-20-063716

Filing Date

2020-03-06

Accepted

2020-03-06 06:30:33

Documents

Period of Report

2020-03-04

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d850507d8k.htm	8-K	22295
2	EX-10.1	d850507dex101.htm	EX-10.1	237701
3	EX-99.1	d850507dex991.htm	EX-99.1	14970
4	EX-99.2	d850507dex992.htm	EX-99.2	15658
	Complete submission text file	0001193125-20-063716.txt		291972

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301

Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740

BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)